Medicine Man Technologies, Inc. (SHWZ) Stock Analysis

Medicine Man Technologies, Inc. (SHWZ) Healthcare & Pipeline Overview

Medicine Man Technologies, Inc. (Schwazze) is a vertically integrated cannabis company operating in Colorado and New Mexico, with retail dispensaries under various banners and wholesale operations. The company cultivates, manufactures, and sells a range of cannabis products, facing competition in a rapidly evolving market.

What Is the Investment Thesis for SHWZ?

Medicine Man Technologies, Inc. (SHWZ) presents a speculative investment opportunity in the cannabis sector. The company's vertically integrated operations in Colorado and New Mexico provide a degree of control over its supply chain and retail channels. However, the company's negative profit margin of -20.0% indicates challenges in achieving profitability. Growth catalysts include expansion within existing markets and potential entry into new states as regulations evolve. The company's beta of 1.32 suggests higher volatility compared to the broader market. Investors should carefully consider the risks associated with the cannabis industry, including regulatory uncertainty and intense competition. The company's ability to improve its profit margins and achieve sustainable growth will be critical to its long-term success.

Based on FMP financials and quantitative analysis

SHWZ Key Highlights

Operates 23 retail cannabis dispensaries under various banners in Colorado as of March 14, 2022.

• Operates 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico as of March 14, 2022.
• Gross Margin of 44.1% indicates a solid ability to control production costs.
• Beta of 1.32 suggests the stock is more volatile than the market average.
• Profit Margin of -20.0% indicates the company is currently operating at a loss.

Who Are SHWZ's Competitors?

SHWZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SHWZ's Key Strengths?

Vertically integrated operations.

• Established retail presence in key markets.
• Diverse product portfolio.
• Multiple dispensary brands.

What Are SHWZ's Weaknesses?

Negative profit margin.

• Limited geographic presence.
• Reliance on evolving regulations.
• High beta indicates greater volatility.

What Could Drive SHWZ Stock Higher?

SHWZ catalyst: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.

• Expansion of retail operations in existing markets.
• Development and introduction of new cannabis products.
• Increasing consumer acceptance of cannabis for medical and recreational use.

What Are the Key Risks for SHWZ?

Financial-distress signal — its Altman Z-Score of -0.16 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-27.5%) — the business is not currently generating profit on shareholder capital.
• Regulatory changes could negatively impact the company's operations.
• Intense competition in the cannabis industry.
• Fluctuations in cannabis prices could affect profitability.
• Limited access to capital could hinder growth.
• Negative profit margin indicates financial instability.

What Are the Growth Opportunities for SHWZ?

• Expansion within Existing Markets: Schwazze can expand its market share in Colorado and New Mexico by opening new dispensaries, introducing new products, and enhancing its marketing efforts. The cannabis markets in these states are expected to continue growing, driven by increasing consumer demand and tourism. By leveraging its existing infrastructure and brand recognition, Schwazze can capitalize on these growth opportunities. The timeline for this expansion is ongoing, with the potential for significant revenue growth over the next few years.
• Entry into New States: As cannabis legalization expands across the United States, Schwazze has the opportunity to enter new markets. By targeting states with favorable regulatory environments and strong growth potential, the company can diversify its revenue streams and increase its overall market presence. This expansion could involve acquisitions, partnerships, or organic growth. The timeline for entering new states depends on regulatory changes, but the potential for long-term growth is significant.
• Product Innovation: Schwazze can drive growth by developing and introducing new cannabis products that cater to evolving consumer preferences. This could include new strains of cannabis, innovative edibles, or advanced vape technologies. By investing in research and development, the company can differentiate its products and capture a larger share of the market. The timeline for product innovation is ongoing, with new products being introduced regularly to meet changing consumer demands. This can lead to increased revenue and brand loyalty.
• Wholesale Expansion: Schwazze can increase its wholesale revenue by expanding its distribution network and supplying cannabis products to other dispensaries and retailers. By building strong relationships with its wholesale customers and offering competitive pricing, the company can capture a larger share of the wholesale market. The timeline for wholesale expansion is ongoing, with the potential for significant revenue growth over the next few years. This strategy leverages the company's cultivation and manufacturing capabilities.
• Strategic Acquisitions: Schwazze can accelerate its growth through strategic acquisitions of other cannabis companies or assets. This could include acquiring cultivation facilities, dispensaries, or brands. By carefully selecting acquisitions that complement its existing operations, Schwazze can expand its market presence, increase its production capacity, and enhance its product portfolio. The timeline for strategic acquisitions is opportunistic, depending on the availability of suitable targets. This can provide a faster route to market expansion compared to organic growth.

What Are SHWZ's Competitive Advantages?

• Vertically integrated operations provide control over the supply chain.
• Established retail presence in Colorado and New Mexico.
• Diverse portfolio of cannabis products.
• Brand recognition through multiple dispensary brands.

What Does SHWZ Do?

Medicine Man Technologies, Inc., doing business as Schwazze, was incorporated in 2014 and is headquartered in Denver, Colorado. The company operates as a cannabis enterprise with a focus on cultivation, manufacturing, and retail sales. Schwazze's operations are divided into three segments: Retail, Wholesale, and Other. The Retail segment encompasses the operation of cannabis dispensaries under various brand names, including Star Buds, Smoking Gun Apothecary, Emerald Fields, Drift, and R. Greenleaf. As of March 14, 2022, Schwazze operated 23 retail cannabis dispensaries in Colorado and 10 medical retail cannabis dispensaries in New Mexico. The Wholesale segment involves the cultivation, manufacturing, and distribution of cannabis products to other dispensaries and retailers. The company offers a variety of cannabis products, including loose flower, concentrates, edibles, pre-rolls, topicals, vape cartridges, and syringes. Additionally, Schwazze provides licensing and consulting, facility design, and facility management services. The 'Other' segment includes the Three A Light publication and the manufacturing, wholesaling, and retailing of plant nutrients for cannabis, along with hydroponics and indoor gardening supplies. Schwazze aims to establish a strong presence in the cannabis market through its vertically integrated operations and diverse product offerings.

What Products and Services Does SHWZ Offer?

• Cultivates cannabis plants in its own facilities.
• Manufactures cannabis products, including concentrates, edibles, and vape cartridges.
• Operates retail cannabis dispensaries under multiple brand names.
• Sells cannabis products directly to consumers through its dispensaries.
• Wholesales cannabis products to other dispensaries and retailers.
• Provides licensing and consulting services to other cannabis businesses.
• Offers facility design and management services for cannabis cultivation facilities.

How Does SHWZ Make Money?

• Generates revenue from the retail sale of cannabis products through its dispensaries.
• Generates revenue from the wholesale of cannabis products to other businesses.
• Generates revenue from licensing and consulting services.
• Generates revenue from the sale of plant nutrients and hydroponics supplies.

What Industry Does SHWZ Operate In?

Medicine Man Technologies, Inc. operates within the rapidly growing cannabis industry, which is characterized by evolving regulations and increasing consumer acceptance. The market is highly competitive, with numerous companies vying for market share in cultivation, manufacturing, and retail. Key trends include the increasing legalization of cannabis for both medical and recreational use, as well as the growing demand for diverse cannabis products. Schwazze competes with other cannabis companies in Colorado and New Mexico, as well as larger multi-state operators. The company's success depends on its ability to differentiate its products, optimize its operations, and navigate the complex regulatory landscape.

Who Are SHWZ's Key Customers?

• Recreational cannabis consumers in Colorado and New Mexico.
• Medical cannabis patients in New Mexico.
• Other cannabis dispensaries and retailers who purchase wholesale products.
• Businesses seeking licensing and consulting services.
• Individuals and businesses purchasing plant nutrients and hydroponics supplies.

Company Profile

Medicine Man Technologies, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Denver, US. The company is led by CEO Forrest Hoffmaster. SHWZ has traded publicly since 2018.

The most recent 12 insider filings for Medicine Man Technologies, Inc. break down as 2 sales and 10 purchases. On net that is roughly 675K shares acquired (about $11K) — insiders putting money in tends to read as conviction.

Medicine Man Technologies, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.16 places it in the distress zone, a signal of elevated financial risk.

Return on equity for Medicine Man Technologies, Inc. stands at -27.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.6%, showing how much profit it generates from its asset base. A current ratio of 0.97 means current liabilities exceed short-term assets, a liquidity point worth watching.

SHWZ Financials

SHWZ Latest News

No recent news available for SHWZ.

SHWZ Analyst Consensus

SHWZ MoonshotScore

Common Questions About SHWZ (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources